Transurethral injection of polyacrylamide hydrogel (Bulkamid (R)) for the treatment of female stress or mixed urinary incontinence

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10284800" target="_blank" >RIV/00216208:11110/14:10284800 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/14:10284800

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.ejogrb.2014.03.033" target="_blank" >http://dx.doi.org/10.1016/j.ejogrb.2014.03.033</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.ejogrb.2014.03.033" target="_blank" >10.1016/j.ejogrb.2014.03.033</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Transurethral injection of polyacrylamide hydrogel (Bulkamid (R)) for the treatment of female stress or mixed urinary incontinence

Popis výsledku v původním jazyce

Objective: The aim of this study was to evaluate the cure effect of a transurethral injection (TUI) of Bulkamid (R) for female urodynamic stress (USI) and stress-predominant mixed urinary incontinence. The hypothesis was that the cure effect of Bulkamid(R) is positive in patients who have undergone previous unsuccessful anti-incontinence surgery and in patients with ISD (Intrinsic Sphincter Deficiency). Study design: This retrospective clinical study was performed on 52 patients for whom previous anti-incontinence surgery had failed (n = 40) and on patients with ISD. Five patients had a reinjection of Bulkamid (R). The efficacy of TUI was evaluated an average of 22 months (minimum - 6 months, maximum - 50 months) after the procedure. Subjective assessment of the leakage of urine was based on the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-UI SF). Objective assessment of leakage of urine was assessed by the cough test. The cure effect of procedures was e

Název v anglickém jazyce

Transurethral injection of polyacrylamide hydrogel (Bulkamid (R)) for the treatment of female stress or mixed urinary incontinence

Popis výsledku anglicky

Objective: The aim of this study was to evaluate the cure effect of a transurethral injection (TUI) of Bulkamid (R) for female urodynamic stress (USI) and stress-predominant mixed urinary incontinence. The hypothesis was that the cure effect of Bulkamid(R) is positive in patients who have undergone previous unsuccessful anti-incontinence surgery and in patients with ISD (Intrinsic Sphincter Deficiency). Study design: This retrospective clinical study was performed on 52 patients for whom previous anti-incontinence surgery had failed (n = 40) and on patients with ISD. Five patients had a reinjection of Bulkamid (R). The efficacy of TUI was evaluated an average of 22 months (minimum - 6 months, maximum - 50 months) after the procedure. Subjective assessment of the leakage of urine was based on the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-UI SF). Objective assessment of leakage of urine was assessed by the cough test. The cure effect of procedures was e

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FK - Gynekologie a porodnictví

OECD FORD obor

—

Projekt

<a href="/cs/project/NT13509" target="_blank" >NT13509: Intrauretrální aplikace Bulkamidu u žen s těžkou inkontinencí moči na podkladě insuficience vnitřního svěrače uretry.</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Journal of Obstetrics, Gynecology and Reproductive Biology

ISSN

0301-2115

e-ISSN

—

Svazek periodika

178

Číslo periodika v rámci svazku

July

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

4

Strana od-do

199-202

Kód UT WoS článku

000339036600037

EID výsledku v databázi Scopus

—